Mutations in the Breast Cancer 1 (BRCA1) gene or Breast Cancer 2 (BRCA2) gene are well-known to substantially increase…
pthomsonSeptember 29, 2022
The Board of Directors of the NanoMedicines Innovation Network (NMIN), a national Networks of Centres of…
pthomsonSeptember 29, 2022
Marburg virus (MARV) infection results in severe viral hemorrhagic fever with mortalities up to 90%,…
pthomsonSeptember 29, 2022
Dr. Michael Kobor has been awarded the 2022 Geoffrey L. Hammond Lectureship. The former, and inaugural,…
pthomsonSeptember 28, 2022
New UBC research could make diagnosis, treatment and prevention more effective for everyone — especially…
pthomsonSeptember 28, 2022
Dr. Grace Cole is investigating the process of blood cell formation. In doing so, they…
pthomsonSeptember 27, 2022
Outside of the lab, Dr. Kerryn Matthews (she/her) is a huge hockey fan; inside the…
pthomsonSeptember 27, 2022
CDRD, Canada’s life sciences venture, TRIUMF, the country’s national particle accelerator centre, and TRIUMF Innovations,…
mjoyApril 8, 2019
Aspect Biosystems, a Canadian biotech company pioneering microfluidic 3D bioprinting of human tissues, is pleased…
sciencecityApril 5, 2019
What happens inside the brain of an opera singer? Prof. Nancy Hermiston, Chair of the…
sciencecityApril 5, 2019
A sun-lit Vancouver building houses a world-renowned team of scientists and researchers. They are oncologists,…
sciencecityApril 3, 2019
If you, loved ones or friends suffer from diseases that may involve abnormal blood clotting,…
sciencecityApril 3, 2019
Tuberculosis (TB) is the world’s deadliest infectious killer but a team of SFU-led researchers is…
sciencecityMarch 28, 2019
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company…
sciencecityMarch 26, 2019
Today, the Government of Canada reaffirmed its longstanding support for TRIUMF with the announcement of a…
sciencecityMarch 22, 2019
